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Stenochlaena palustris fronds are popular as a vegetable in Southeast Asia. The objectives of
this study were to evaluate the anticholinesterase properties and phytochemical profiles of
the young and mature fronds of this plant. Both types of fronds were found to have se-
lective inhibitory effect against butyrylcholinesterase compared with acetylcholinesterase.
However, different sets of compounds were responsible for their activity. In young fronds,
an antibutyrylcholinesterase effect was observed in the hexane extract, which was
comprised of a variety of aliphatic hydrocarbons, fatty acids, and phytosterols. In the
mature fronds, inhibitory activity was observed in the methanol extract, which contained a
series of kaempferol glycosides. Our results provided novel information concerning the
ability of S. palustris to inhibit cholinesterase and its phytochemical profile. Further
research to investigate the potential use of this plant against Alzheimer's disease is war-
ranted, however, young and mature fronds should be distinguished due to their phyto-
chemical differences.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The central cholinergic system plays a key role in the regu-
lation of cognitive functions. Damage in such systems is
thought to be responsible for cognitive decline, which is theearch, Universiti Sains M
).
inistration, Taiwan. Publis
/licenses/by-nc-nd/3.0/).key features of Alzheimer's disease (AD), dementia, and other
neurodegenerative diseases [1]. Since cholinergic markers
have been found to be greatly reduced in the postmortem
brain samples of AD patients, and the decline in neuro-
transmitter acetylcholine can be correlated to the degree of
cognitive impairment [2], inhibition of cholinesterasesalaysia, 11800 USM, Penang, Malaysia.
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plausible strategy for the treatment and control of memory
loss associated with AD [3]. A number of foods from plants
have been found to exhibit anticholinesterase activity. These
include ginger [4], a blend of black chokeberry, and lemon
juice [5], as well as green tea [6]. Other plant species con-
taining alkaloids, xanthones, and polyphenols [7e9] have also
been reported to exert inhibitory effects on cholinesterase
and, thus, have potential applications in prevention of
cognitive decline.
In this study, we evaluated the potential of a vegetable
fern, Stenochlaena palustris, to inhibit cholinesterases and the
phytochemicals involved. S. palustris is known as ‘Paku
Miding’ in Malaysia, or ‘Kalakai” in Borneo and Kalimantan.
It is a creeping fern found widely across India, through
Malaysia and Polynesia, and into Australia [10]. The S. pal-
ustris frond is dimorphic and can be classified as fertile or
sterile based on morphology. Fertile fronds have thin, long
pinnae that bear spores, and are seasonal and inedible.
However, the sterile fronds that are edible have broad pinnae
with sharply toothed margins and are available throughout
the year [11]. The young, sterile fronds of the fern have a
crispy texture and are usually cooked with shrimp paste into
a vegetable dish. They are also used traditionally to treat
fever, diarrhea, skin diseases, cutaneous disorders, and
gastric ulcers [11e13]. According to the Malaysian Agricul-
tural and Development Institute, S. palustris has great po-
tential to be exported to foreignmarkets. Therefore, research
has been carried out to improve postharvest handling and
packaging conditions in order to extend the storage period of
the plant [14]. Furthermore, effort has also been undertaken
to evaluate its cultivation and economic potential [15].
Despite having great promise in the food market, informa-
tion concerning its health functions and nutritive properties
remained scarce.
There have been accounts concerning the antifungal ac-
tivity of the methanolic leaf extract [16] and antibacterial
properties of flavonol glycosides [17] from S. palustris. Addi-
tionally, other researchers, including our group, found strong
antioxidant activities and high polyphenolic content in the
fronds [18e20]. Given that natural antioxidants may have
potential in treating AD due to their neuroprotective proper-
ties [21,22], we explored the neuroprotective potential of S.
palustris by evaluating its cholinesterase inhibitory properties.
This study was carried out on young, sterile fronds, which are
commonly consumed as vegetables, as well as on the mature
sterile fronds, which are not usually eaten, in order to verify
differences between them.2. Materials and methods
2.1. Plant material
S. palustris (Burm.). Bedd. (Blechnaceae) was collected from
Sungai Petani, Kedah, Malaysia. The taxonomic identity of the
plant was authenticated by Ms Maliga Gnasan, a botanist at
the Penang Botanic Gardens. A voucher specimen (No. 1645)
was then deposited at the premises.2.2. Chemicals and reagents
Hexane, dichloromethane (DCM), and methanol (MeOH) used
for the extraction of plant materials were of analytical grade
(Merck, Darmstadt, Germany). Reagents and standards used
for estimating the total phenolic content and total flavonoid
assays were: Folin-ciocalteu and quercetin hydrate from
Sigma-Aldrich (St. Louis, MO, USA); sodiumcarbonate, sodium
hydroxide, and sodium nitrite from Classic Chemicals (Shah
Alam, Malaysia); gallic acid and aluminum chloride from
Merck. For the anticholinesterase assay, acetylthiocholine
iodide and acetylcholinesterase from electric eel, bovine
serum albumin, 5,50-dithiobis (2-nitrobenzoic acid), and
butyrylcholinesterase from equine serum, and S-butyrylth-
iocholine chloride and physostigmine were purchased from
Sigma-Aldrich.
2.3. Extraction of plant material
Prior to carrying out the extraction, young and mature fronds
were separated based on their physical appearance. The
young fronds are tender, juicy, and have a reddisheorange
hue, whilemature fronds are stiff and pure light green in color
(Fig. S1). Upon separation, the fronds were cleaned, freeze-
dried, and subsequently pulverized with a mill grinder. The
powdered materials were extracted sequentially with n-hex-
ane, DCM, and MeOH, twice for each solvent and for 20 mi-
nutes for each extraction, in a B-5510 ultrasonic cleaning bath
operating at 42 kHz and 135 kW (Branson Ultrasonics Corpo-
ration, Danbury, CT, USA). The extracts obtained for each
solvent were combined, filtered, and evaporated to dryness
under reduced pressure at temperature < 40C. The percent-
age yield of each plant extract was calculated based on the
weight of the dried extract obtained (g) for every g of dried
plant material used.
2.4. Cholinesterase inhibitory assay
Cholinesterase inhibitory potential of the samples was
determined using a spectrophotometric method that was
modified from that described by Ellman et al [23]. For the
acetylcholinesterase (AChE) inhibition assay, 140 mL 0.1M
Na2PO4 buffer (pH 8) was added to a 96-well microplate, fol-
lowed by the addition of 20 mL test sample and 20 mL acetyl-
cholinesterase enzyme (0.09 U/mL). Ten microliters 10mM
5,50-dithiobis (2-nitrobenzoic acid) was then added to each
well, followed by addition of 10 mL acetylthiocholine iodide
(14mM). The absorbance of the colored end-product was
measured at 412 nm at designated intervals for 30 minutes
after initiation of the enzymatic reaction by a Infinite 200
ProMicroplate Spectrometer (Tecan, M€annedorf, Switzerland).
For the butyrylcholinesterase (BChE) inhibition assay, the
same procedure as described for AChEwas followed; however,
the enzymes and substrates were substituted with butyr-
ylcholinesterase from equine serum and S-butyrylthiocholine
chloride, respectively.
A set of five concentrations of each plant extract or isolated
compound was used to estimate the 50% inhibitory concen-
tration (IC50). Physostigmine, a cholinesterase inhibitor, was
used as the reference standard. Absorbance of the test
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respective blank. Percentage inhibition was calculated using
the following formula:
Inhibition (%) ¼ (Abscontrol e Abssample)/(Abscontrol)  100
2.5. Phytochemical investigation
2.5.1. Gas chromatography-mass spectrometry analysis
Gas chromatography-mass spectrometry analysis (GC-MS)
analyses of the hexane extract of both young and mature
fronds was carried out on an Agilent 6890N Network GC sys-
tem coupled to an Agilent 5973i Mass Selective Detector
(Agilent Technologies, Waldbronn, Germany). Separation of
the chemical compounds was achieved on an HP-5MS column
(30 m  0.25 mm, 0.25 mm; Agilent Technologies) with helium
as the carrier gas flowing at 1.2 mL/min. The injection volume
was 10 mL in a splitless mode. Initial temperature of the oven
was 70 C for 2 minutes, which was increased to 280C at the
rate of 20C/min. The column temperature was then main-
tained at 280C for 20minutes. The temperature of the injector
was set at 280C, while the temperature of the detector was
250C. Mass acquisition was performed in the range of 40e550
a.m.u. using electron-impact ionization at 70 eV. Identifica-
tion of the chemical components was done by performing
spectralmatch against the National Institute of Standards and
Technology database (Gaithersburg, MD, USA) and the Wiley
Registry (John Wiley and Sons, Hoboken, NJ, USA). Similarity
between the MS spectrum of the compounds and those in the
database was evaluated by comparing the mass of their mo-
lecular ions, base ions, fragment ions, as well as their peak
intensities. Only those compounds with >90% spectral
matching quality were considered acceptable.
2.5.2. Total phenolic content
Total phenolic content (TPC) in theMeOH extract of S. palustris
young and mature fronds was determined according to the
method reported by Singleston and Rossi [24], with minor
modifications. Briefly, 150 mL of each extract (1 mg/mL in
MeOH) was diluted with 2.4 mL distilled water, followed by
addition of 1 mL 0.2N Folin-Ciocalteu reagent, after which the
solution was allowed to react for 5 minutes. Then, 300 mL of
saturated Na2CO3 solution was added, and the mixture was
allowed to incubate for 2 hours in the dark. An aliquot of
200 mL of the mixture was then transferred to a 96-well plate
and the optical density was recorded at 725 nm using a
microplate spectrophotometer (Multiskan Go; Thermo Scien-
tific, Carlsbad, CA, USA). TPC of the samples was estimated
from the calibration curve of gallic acid standard in the range
of 0.01e0.1 mg/mL, and results were expressed as mg of gallic
acid equivalents per gram of dry extract (mg GAE/g).
2.5.3. Total flavonoid content
Total flavonoid content (TFC) of the MeOH extracts was
determined by the method developed by Sakanaka et al [25]
with slight modifications. Briefly, 250 mL of plant extracts
(1mg/mL) weremixedwith 1250 mL distilledwater and 75 mL of5% NaNO2 in a test tube. The mixture was incubated for
6 minutes, after which 150 mL of 10% AlCl3 solution was added
to the mixture, and the reaction was allowed continue for
5 minutes. Then, 500 mL 1M NaOH was added and the mixture
was brought to 2.5 mL with distilled water and stirred to mix
well. An aliquot of 200 mL of the mixture was then transferred
to a 96-well plate where the absorbance was measured
immediately at 510 nm. TFC of the samples was determined
from the calibration curve of the quercetin standard in the
range of 0.01e0.1 mg/mL. Results were expressed in mg of
quercetin equivalents per gram of dry extract (mg QE/g).
2.5.4. Phytochemical comparison by high-performance thin-
layer chromatography
The phytochemicals present in the young fronds of S. palustris
were qualitatively comparedwith that of themature fronds by
phytochemical comparison by high-performance thin-layer
chromatography (HPTLC). Briefly, a solution of MeOH extract
from each samplewas prepared at 10mg/mL inMeOH. A 10-mL
aliquot was then spotted on a silica gel 60 HPTLC plate (Merck)
and developed using a mobile-phase system that consisted of
ethyl acetate (EtOAc), MeOH, and 1% acetic acid (8:1:1, v/v/v).
The HPTLC plate was then treated with 1% AlCl3 and visual-
ized at 365 nm. Yellow fluorescent bands were observed as an
indication of the presence of flavonoids.
2.5.5. Flavonoid isolation and identification
Dried MeOH extract from the mature fronds (50 g) was parti-
tioned between EtOAc and water. The EtOAc-soluble portion
was subjected to vacuum liquid chromatography on a silica
gel (4.5 cm  15.0 cm) using a step gradient of hexane-EtOAc-
MeOH (5:5:0 to 0:0:10, v/v/v) to yield seven fractions (F1eF7).
Purification of F1 was performed using silica gel flash-column
chromatography (5.0 cm 30 cm) at a flow rate of ~10mL/min
using a step gradient of hexane-CHCl3-MeOH (5:5:0 to 0:0:10, v/
v/v; 15 mL fractions), followed by Sephadex LH-20
(2.5 cm  30 cm, MeOH; 5 mL fractions; Sigma-Aldrich (St.
Louis, MO, USA)), and subsequently prep-TLC with the devel-
oping solvent of CHCl3-MeOH (4.3: 0.7, v/v) to afford Com-
pounds 14e18. Purification of F3 and F4 was achieved by
Sephadex LH-20 (2.5 cm  30 cm, MeOH; 5 mL fractions), fol-
lowed by prep-TLC with a mobile phase system of EtOAc-
MeOH-1% CH3COOH (8:1:1, v/v/v) to afford Compounds 13
and 19, respectively.
One- and two-dimensional nuclear magnetic resonance
(NMR) spectroscopic data of the compounds was recorded on
an Avance 500 NMR Spectrometer (Bruker, Vienna, Austria),
while electrospray ionization-MS was obtained in negative
mode on an AmaZon X mass spectrometer (Bruker). The iso-
lated compounds were identified as kaempferol 3-O-b-gluco-
pyranoside ([M-H] ¼ m/z 447.1; fragment ion m/z 284.8;
Compound 13), kaempferol 3-O-(300-O-E-p-coumaroyl)-(600-O-E-
feruloyl)-b-glucopyranoside ([M-H] ¼ m/z 769.3; fragment
ions m/z 623.2, 593.2, 446.9, and 284.7; Compound 14),
kaempferol 3-O-(300,600-di-O-E-p-coumaroyl)-b-glucopyrano-
side ([M-H] ¼ m/z 739.3; fragment ions m/z 593.2, 446.9, and
284.7; Compound 15), kaempferol 3-O-(600-O-E-p-coumaroyl)-
b-glucopyranoside ([M-H] ¼ m/z 593.2; fragment ions m/z
446.9 and 284.7; Compound 16), kaempferol 3-O-(300-O-E-p-
coumaroyl)-b-glucopyranoside ([M-H] ¼ m/z 593.2; fragment
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rhamnopyranoside ([M-H] ¼ m/z 431.0; fragment ion m/z
284.7; Compound 18), and kaempferol 3-O-(600-O-a-rhamno-
pyranoside)-b-glucopyranoside ([M-H] ¼ m/z 593.2; fragment
ion m/z 284.6; Compound 19). NMR data for the compounds
were in agreement with that reported in the literature
[17,26e28].2.6. Statistical analysis
Differences between the extraction yield of young andmature
frond extracts was evaluated using Student t test at a 99.9%
confidence interval. The relationship between TPC and TFC of
the MeOH extracts were evaluated using Pearson's correlation
study. All statistical analyses were performed using SPSS
software version 18.0 (SPSS, Inc., Chicago, IL, USA).3. Results and discussion
3.1. Total distribution of plant metabolites
The total distribution of plant metabolites in the fronds of S.
palustris at two different stages of maturity was compared by
evaluating the extraction yield obtained using solvents of
varying polarity. Among the hexane extracts, young fronds
were found to produce higher extraction yields compared
with the mature fronds, indicating that there are more lipo-
philic substances at the early stage of growth (Fig. 1). As the
fronds mature, the content of lipophilic substances reduces,
however, the production of hydrophilic compounds increases.
This was shown by the higher extraction yield in both MeOH
and DCM extracts in the mature fronds compared with the
young fronds. These results indicated a change in biosyn-
thesis and distribution of plant metabolites at different
growth stages of S. palustris fronds.Fig. 1 e Extraction yield of young and mature sterile fronds
obtained using various solvents (results are mean ± SEM,
n ¼ 4). Significant differences (p < 0.01) were found
between the extracts of young and mature fronds obtained
with each solvent. SEM ¼ standard error of the mean;
DCM ¼ dichloromethane; MeOH ¼ methanol.3.2. Cholinesterase inhibitory activity
Cholinesterase inhibitors have been shown clinically to be one
of the most promising and preferred treatment for AD due to
its efficacy and less severe side effects [29]. Two forms of
cholinesterases that are the targets for inhibition are AChE
and BChE, and in normal human brains, the activity of AChE
predominates over BChE. As AD progresses, the activity of
AChE declines in certain brain regions to 10e15% of normal
activity, whereas BChE activity rises to partially compensate
for the loss in AChE activity [30]. In terms of kinetic response,
while AChE becomes substrate inhibited at high concentra-
tions, BChE shows high efficiency in hydrolyzing acetylcho-
line at the corresponding concentration [31]. Hence, inhibition
of both enzymes has complimentary implications in the
treatment of mild-to-severe forms of AD.
In this study, the ability of S. palustris frond extracts to
inhibit AChE and BChE were evaluated. The effects of various
extracts from the young fronds toward cholinesterase en-
zymes were different compared with those of mature fronds
(Table 1). The hexane extracts from young fronds showed
prominent inhibitory effects against BChE, while the hexane
extracts from the mature fronds exhibited 10-fold less inhibi-
tion of the same enzyme. By contrast, theMeOH extracts from
the mature fronds showed strong activity against BChE and
mild inhibitory effects against AChE, while the same type of
extract from the young fronds exhibited no appreciable inhi-
bition of both cholinesterases. DCM extracts from both young
andmature frondswere inactive against the twoenzymes.Our
results indicated that S. palustris appeared to selectively inhibit
BChE toa greater extent relative toAChE.This suggests that the
plant may have potential applications in AD treatment at the
moderate-to-advanced stages. In view of the vast differences
in cholinesterase inhibitory activities between the extracts of
young and the mature fronds, further analyses were carried
out to compare phytochemical differences.3.3. Phytochemical comparison
3.3.1. Hexane extracts
The hexane extracts from young and mature fronds were
subjected to GC-MS analysis at a fixed concentration of 1 mg/Table 1 e Cholinesterase inhibitory activity of
Stenochlaena palustris.
Sample IC50 (mg/mL), mean ± SD
AChE BChE
Hexane extract Young fronds >200 9.74 ± 0.33
Mature fronds >200 130.54 ± 13.46
DCM extract Young fronds >200 >200
Mature fronds >200 >200
MeOH extract Young fronds >200 >200
Mature fronds 121.02 ± 10.04 19.77 ± 1.08
Physostigmine 0.05 ± 0.01 0.16 ± 0.02
AChE ¼ acetylcholinesterase; BChE ¼ butyrylcholinesterase;
IC50 ¼ concentration of a substance required to inhibit an enzy-
matic process by half; DCM ¼ dichloromethane; SD ¼ standard
deviation.
Table 2 e Relative amount of chemical constituents in
young and mature fronds of Stenochlaena palustris.
Peak
labels
Retention
time (min)
Compound Peak area (%)a
Young
fronds
Mature
fronds
1 10.27 Neophytadiene 43.33 d
2 10.50 trans-phytol 12.22 d
3 10.73 Methyl palmitate 8.33 d
4 10.93 Palmitic acid 13.89 15
5 11.56 Methyl linoleate 8.33 d
6 11.79 Linoleic acid 12.22 d
7 12.33 Ethyl arachidonate 4.44 d
8 19.40 a-tocopherol d 72.22
9 21.25 Campesterol 10 22.22
10 21.88 Stigmasterol 2.78 22.22
11 23.13 b-sitosterol 57.78 100
12 23.52 Fucosterol 10 d
a Percentage of peak area relative to the largest peak, b-sitosterol,
which is set at 100%.
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Table S1. Both samples were found to contain different vari-
eties and concentrations of phytochemicals. The young
frondswere rich in aliphatic compounds, essential fatty acids,
and phytosterols. By contrast, the mature fronds contained
relatively fewer constituents (Fig. 2). The main lipophilic
components in the mature fronds were a-tocopherol and a
number of phytosterols, while no aliphatic compounds or
fatty acids were detected in the mature fronds, except for a
trace amount of palmitic acid (Table 2). The presence of a-
tocopherol and the phytosterols seemed to have little contri-
bution to the cholinesterase activity of the extract, as the BChE
inhibitory effect of the mature fronds was >10-fold weaker
than that of the young fronds. Previous studies showed that b-
sitosterol alone had no appreciable inhibitory effect on either
AChE or BChE [32]. However, the presence of aliphatic hy-
drocarbons and fatty acids, as well as sterols, resulted in
strong BChE inhibitory activity observed in the extracts from
the young fronds, indicating the possibility of contributions by
the aliphatic compounds toward anticholinesterase activity.
Further work is required in order to confirm this finding. It
should be noted that the variety of chemical constituents
found in the hexane extract from the two frondsFig. 2 e A representative GC-MS chromatogram (TIC) of (A)
young and (B) mature fronds of Stenochlaena palustris. The
identity of the compounds: 1 ¼ neophytadiene; 2 ¼ trans-
phytol; 3¼methyl palmitate; 4¼ palmitic acid; 5¼methyl
linoleate; 6 ¼ linoleic acid; 7 ¼ ethyl arachidonate; 8 ¼ a-
tocopherol; 9 ¼ campesterol; 10 ¼ stigmasterol; 11 ¼ b-
sitosterol; and 12 ¼ fucosterol. GC-MS ¼ gas
chromatography mass spectrometry; TIC ¼ total ion
chromatogram.corresponded well with the extraction yield of the extracts.
Greater constituent variety was observed in the extracts from
the young fronds, which were obtained at higher yields
comparedwith the fewer constituents obtained in the extracts
from the mature fronds, which were obtained at lower yields.
Two components that were found to be mutually exclusive
to each type of frond were fucosterol and a-tocopherol
(Vitamin E). Fucosterol was found only in the hexane extract
from the young fronds, while a-tocopherol was present only in
the hexane extract from the mature fronds. Fucosterol is a
precursor of b-sitosterol in the phytosterol biosynthesis
pathway [33]. Therefore, the presence of fucosterol in young
fronds suggests that the compound is not fully converted to b-
sitosterol at the early stage of frond development. Fucosterol
had been reported to possess weak BChE inhibitory activity
[34], indicating that the compound may also partially
contribute to overall anti-BChE activity observed in extracts
from the young frond. a-Tocopherol was found in great
abundance in the mature fronds. Although this compound
has no direct effect on the anticholinesterase activities of the
fern, it was reported to exert protective effects against
neuronal cell death caused by oxidative stress [35]. These re-
sults suggested that the hexane extracts from both young and
mature fronds of S. palustris play independent roles in
neuroprotection.
3.3.2. Methanol extracts
To compare the phytochemicals between the MeOH extracts
from young and mature fronds, TPC and TFC were first eval-
uated. As presented in Table 3, both young andmature fronds
were found to have high content of polyphenols and flavo-
noids, in agreement with the findings of Chai et al [18]. How-
ever, TPC and TFC were approximately twofold higher in the
mature fronds relative to the young fronds. The amount of
phenolic substances present in 1 g of MeOH extract from the
mature fronds was equivalent to ~1/4 g of gallic acid activity,
while in the young fronds, the amount was only slightly >1/
10 g gallic acid activity/g of extract. The flavonoid content in
1 g of the extract frommature fronds was equivalent to ~1/2 g
Table 3 e Total phenolic and flavonoid content of the
methanol extract from young and mature fronds of
Stenochlaena palustris.
Sample Total phenolic
content
(mg GAE/g extract)
Total flavonoid
content
(mg QE/g extract)
Coefficient of
determination
(r2)
Young
fronds
94.15 ± 4.64 205.66 ± 0.07 0.912
Mature
fronds
252.32 ± 13.27 503.56 ± 35.54 0.988
GAE ¼ gallic acid equivalent; QE ¼ quercetin equivalent.
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young fronds contain flavonoids equivalent to 1/5 g of quer-
cetin activity. The high TPC values were found to be strongly
correlated to their flavonoid content, as statistical analyses for
the MeOH extract of both young and mature fronds showed
r2 > 0.9 (Table 3).
To further understand the differences observed in TPC and
TFC values between the young and mature fronds, chemical
constituents of both types of frond extracts were evaluated by
HPTLC. Following postchromatographic treatment with AlCl3,
flavonoid constituents were observed (Fig. 3). Based on our
analysis, mature fronds contained a greater variety of flavo-
noids compared with the young fronds. The identity of these
flavonoids were further determined by various spectroscopic
techniques following isolation of the compounds and were
found to be a series of kaempferol glycosides (Fig. 4). Among
these substances, only kaempferol 3-O-b-glucopyranoside
(Compound 13) was common to both young and mature
fronds. The other flavonoids, which are derivatives of Com-
pound 13, were found exclusively in the mature fronds. ThisFig. 3 e HPTLC of the MeOH extract from young fronds (YF) and
AlCl3 reagent. Flavonoids turned from dark to yellow fluorescen
compounds are: kaempferol 3-O-b-glucopyranoside (Compound
b-glucopyranoside (Compound 14), kaempferol 3-O-(300,600-di-O-E
kaempferol 3-O-(600-O-E-p-coumaroyl)-b-glucopyranoside (Comp
glucopyranoside (Compound 17), kaempferol 3-O-a-rhamnopyr
rhamnopyranoside)-b-glucopyranoside (Compound 19). HPTLC
MeOH ¼ methanol.indicates that, as the fronds mature, S. palustris tends to
synthesize more complex molecules from its principal flavo-
noid, kaempferol 3-O-b-glucopyranoside (Compound 13).
Large varieties and concentrations of such complex flavonoid
molecules were likely to be the major contributors to the high
TPC and TFC values observed in the MeOH extracts from
mature fronds. The results were also consistent with the
higher extraction yields observed in the MeOH extracts from
mature fronds compared with the young fronds as discussed
earlier in Section 3.1. Interestingly, the high anticholines-
terase activity observed in the MeOH extract from mature
fronds also corresponded well with its high content of flavo-
noids, suggesting a possible contribution of the kaempferol
glycosides to the cholinesterase inhibitory effect outlined in
Table 1. This is supported by a study reporting the effect of a
variety of flavonols and their glycosides as cholinesterase in-
hibitors [36]. One of the compounds identified in this study,
kaempferol 3-O-(600-O-E-p-coumaroyl)-b-glucopyranoside
(Compound 16), was also reported to have strong inhibitory
effects on AChE, while the inhibitory effects on BChE have not
yet been evaluated [37].
To verify whether the isolated kaempferol glycosides
(Compounds 13e19) contributed to the anticholinesterase
activity of the MeOH extracts, the individual compounds were
evaluated for their ability to inhibit BChE. Of the seven com-
pounds, two diacylated kaempferol glycosides, kaempferol 3-
O-(300-O-E-p-coumaroyl)-(600-O-E-feruloyl)-b-glucopyranoside
(Compound 14) and kaempferol 3-O-(300,600-di-O-E-p-cou-
maroyl)-b-glucopyranoside (Compound 15), showedmoderate
inhibitory effects on BChE, with IC50 values of 87.44 mg/mL and
63.12 mg/mL, respectively (Table 4). The rest of the constitu-
ents appeared to have very mild inhibitory activities on the
enzyme at the test concentration of 100 mg/mL. Based on the
structure of the compounds, acylation of the kaempferolmature fronds (MF). (A) Before and (B) after treatment with
t bands after treatment with AlCl3. The identity of the
13), kaempferol 3-O-(300-O-E-p-coumaroyl)-(600-O-E-feruloyl)-
-p-coumaroyl)-b-glucopyranoside (Compound 15),
ound 16, kaempferol 3-O-(300-O-E-p-coumaroyl)-b-
anoside (Compound 18), and kaempferol 3-O-(600-O-a-
¼ high-performance thin-layer chromatography;
Fig. 4 e Kaempferol glycosides isolated from the mature sterile fronds of Stenochlaena palustris. The identity of the
compounds: kaempferol 3-O-b-glucopyranoside (Compound 13), kaempferol 3-O-(300-O-E-p-coumaroyl)-(600-O-E-feruloyl)-b-
glucopyranoside (Compound 14), kaempferol 3-O-(300,600-di-O-E-p-coumaroyl)-b-glucopyranoside (Compound 15),
kaempferol 3-O-(600-O-E-p-coumaroyl)-b-glucopyranoside (Compound 16), kaempferol 3-O-(300-O-E-p-coumaroyl)-b-
glucopyranoside (Compound 17), kaempferol 3-O-a-rhamnopyranoside (Compound 18), and kaempferol 3-O-(600-O-a-
rhamnopyranoside)-b-glucopyranoside (Compound 19).
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and 600 of the glucose unit seemed to contribute greatly to the
inhibitory effects of the kaempferol glycosides on BChE.
However, by comparing the activity of Compound 14 to
Compound 15, the former had a ferulyol moiety at position 600
and demonstrated a lower inhibitory potential against BChE
compared with the latter, which had a p-coumaroyl moiety at
the same position. This suggested that substitution of a meta-
hydrogen with a methoxy group on the hydroxycinnamyol
unit reduced the activity of the compound. Nevertheless, the
weaker anti-BChE activity of the individual compounds as
compared to the MeOH extracts from which they were iso-
lated indicated that no single compound may be solelyTable 4 e BChE inhibitory activity of kaempferol
glycosides of Stenochlaena palustris fronds.
Compound % Inhibition
at 100 mg/mLa
IC50, mg/mL (mM)
a
13 7.45 ± 0.72 ND
14 54.18 ± 2.93 87.44 ± 5.86 (113.66 ± 7.66)
15 52.10 ± 1.11 63.12 ± 6.12 (85.37 ± 7.62)
16 16.82 ± 2.18 ND
17 6.90 ± 0.67 ND
18 9.45 ± 1.17 ND
19 0 ND
Physostigmine 94.94 ± 0.04 0.16 ± 0.02 (0.59 ± 0.07)
BChE ¼ butyrylcholinesterase; IC50 ¼ concentration of a substance
required to inhibit an enzymatic process by half; ND ¼ not deter-
mined; SD ¼ standard deviation.
a Data presented as mean ± SD (n ¼ 3).responsible for the activity of the extract. The prominent
anticholinesterase activity of the MeOH extracts from mature
fronds may be due to a complex synergism between the fla-
vonoids and other constituents that were not determined in
this study.
The fate of the acylated kaempferol glycosides isolated
from S. palustris when entering the in vivo system remains
uncertain. However, it can be assumed that these molecules
will largely undergo hydrolysis when ingested to form two
basic units, consisting of kaempferol aglycone and hydrox-
ycinnamic acid, through cleavage of the glycosidic bonds by
enteric enzymes and colon microflora [38]. These liberated
molecules are reported to have better absorption efficacy than
pure kaempferol [39,40]. Numerous studies showed that free
kaempferol and hydroxycinnamic acids were potent natural
cholinesterase inhibitors, with this a key target in AD treat-
ment [36,41,42]. Behavioral studies on mice with valium-
impaired memory and using a radial arm maze model
showed that kaempferol administration significantly
improved the spatial learning and memory of the mice [43].
Additionally, simple hydroxycinnamic acids, such as p-cou-
maric and ferulic acid, were reported to attenuate b-amyloid-
induced neurotoxicity in mice by binding to acetycholine and
destabilizing the structure of the growing b-amyloid fibrils
[42]. Although the acylated glycosides may be hydrolyzed
in vivo, they could still play a role as precursors for pharma-
cologically active kaempferol and hydroxycinnamic acids.
Nevertheless, if the acylated kaempferol glycosides are to be
taken with other S. palustris constituents in the form of an
extract, in vivo transformation of these compounds may vary,
as the presence of multiple components in plants may help
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 3 5 8e3 6 6 365stabilize one another against enzymatic degradation and
enhance their solubility in water [44]. An example of a plant
extract containing acylated flavonol glycosides and that has
been experimentally and clinically shown to increase cogni-
tive functions is the standardized Gingko biloba leaf extract,
EGb 761 [45]. Future studies should concentrate on the phar-
macodynamics and pharmacokinetics of S. palustris extracts
and its individual kaempferol glycosides in order to further
explore their potential contribution toward AD treatment.4. Conclusion
This study demonstrated that S. palustris exhibits selective
inhibitory effects on BChE. The distribution of phytochemicals
in S. palustris fronds at different stages of maturity varies,
thereby resulting in a great contrast in cholinesterase inhibi-
tory activity from the same type of extracts. Extracts from
young fronds contain a mixture of aliphatic substances, fatty
acids, and phytosterols, while extracts from active mature
fronds contain a variety of kaempferol glycosides. The indi-
vidual kaempferol glycoside isolated from the plantwas found
to have weaker anti-BChE activity relative to the extract from
which they were isolated. Based on these findings, the edible
young fronds of S. palustris have potential as a functional food
to prevent cognitive decline. Themature fronds should also be
explored for their potential as a therapeutic for AD. It is critical
to clearly define the stage of frond maturity in future S. pal-
ustris investigations due to the distinction between young and
mature fronds in terms of chemistry, biology, and their po-
tential contribution to human health.Conflicts of Interest
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